Tumor-derived Vimentin as a novel biomarker for distinct subtypes predicting adjuvant chemotherapy resistance and T-cell-inflamed phenotype in small cell lung cancer.

MedComm (2020) · 2023 · PMC10542987 · PMID 37789961

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

nearly significantp = 0.073so close (0.05 < p ≤ 0.1)

In the entire cohort, this molecular subtype model had prognostic value for OS ( p = 0.001, Figure 3A ) and nearly significant for RFS ( p = 0.073, Figure S2A ).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.